Active Pharmaceutical Ingredient(API)

Products Specification Document
Anastrazole USP/BP/IP T.P
Abiraterone USP/IP T.P
Bendamustine IP T.P
Capacitabine USP/BP/IP T.P
Erlotinib IP T.P
Gefitinib IP/BP T.P
Imatinib IP/BP T.P
Bicalutamide Tab. USP/BP/IP T.P
Products Specification Document
Busulfan Inj. USP/BP T.P
Gemcitabine HCl Inj. USP/BP/IP T.P
Irinotecan HCl USP/BP/IP T.P
Methotrexate Inj. / Tab. USP/BP/IP T.P
Topotecan Inj. IP T.P
Cyterabine Inj. USP/BP/IP T.P
Thiotepa Inj. USP/BP/IP T.P
Products Specification Document
Aprepritant USP/BP/IP R&D
Clofarabine IHS R&D
Carboplatin USP/BP/IP R&D
Cisplatin USP/BP/IP R&D
Carmustine USP/BP/IP R&D
Docetaxel USP/BP/IP R&D
Etoposide USP/BP/IP R&D
Products Specification Document
Fosaprepitant IHS R&D
Lenalidomide IHS R&D
Letrozole USP/BP/IP R&D
Oxaliplatin USP/BP/IP R&D
Ondansetron USP/BP/IP R&D
Pemetrexed Dipotassium USP/BP/IP R&D
Temozolamide USP/BP/IP R&D
Products Specification Document
Axitinib IHS R&D
Azacitadine IP R&D
Afatinib IHS R&D
Bortezomib IP R&D
Cyclophosphamide USP/BP/IP R&D
Carfilozomib IHS R&D
Dasatinib IHS R&D
Decitabine IHS R&D
Doxorubicin HCl USP/BP/IP R&D
Daunorubicin USP/BP/IP R&D
Dutasteride USP/BP/IP R&D
Exemestane USP/BP/IP R&D
Evrolimus IHS R&D
Enzalutamide IHS R&D
Epirubicin USP/BP R&D
Products Specification Document
Fulvestrant USP/BP/IP R&D
Efosfamide IHS R&D
Granosetron IHS R&D
Hydroxy Urea USP/BP/IP R&D
Lapatinib IP R&D
Leucovorin Calcium USP/IP R&D
Pazopanib IHS R&D
Pomalidomide IHS R&D
Sorafenib IP R&D
Sunitinib IHS R&D
Tegafur & Uracil JP R&D
Tamoxifen USP/BP/IP R&D
Vincristine USP/BP/IP R&D
Vinblastine USP/BP/IP R&D
Zolendronic Acid IP R&D
*T.P = Technical Package *BP = British Pharmacopeia
*IHS = In-House Standard *IP = Indian Pharmacopeia
*USP = United States Pharmacopeia